| Nordic_Bioscience_Diagnostics Develops immunodiagnostic products to identify diseases affecting bone and cartilage. |
| Novartis Created by the merger of Ciba and Sandoz. Has core businesses in healthcare, agribusiness and consumer health. |
| Novozymes_Biotech,_Inc_ Emphasizes research in identifying and engineering new industrial enzymes as well as improving the manufacturing process for new and existing enzymes. |
| Novozymes_com Creates bio-industrial products by using enzymes for such things as waste water cleanup, house cleaners and lawn maintenance. Provides contact information. |
| Orchid_BioSciences Develops products and services designed to measure and use in pharmacogenetics and drug discovery. |
| PCS_Process_Control_Systems_AG Solution provider for the automation of biotechnological and pharmaceutical processes. Based in Switzerland. |
| Pepscan_Systems Focused on the use of the knowledge of molecular recognition. |
| Phage_Biotech,_Ltd_ Presents a valid biological solution to the chemical antibiotics crisis. |
| Phycotransgenics_LLC Specializes in the development of transgenic microalgae to be used for animal health, animal feed, bioremediation, environmental monitoring and biopesticides. Includes information about the company |
| PinkCell_Laboratories An antibody developing company in the Netherlands, offering OEM products and antibody-developing services. Site includes details of products, services and positions vacant. |
| Plant_Research_International Offer research services in plant genetics and reproduction, crop physiology, agrosystems, soil fertility, and the optimization of plant health. |
| Precision_Therapeutics,_Inc_ Focusing on the interaction of cultivated tumor cells with chemotherapy and immunology-based drugs. |
| PrimeGen_Biotech_Corporation Specializes in stem cell research The purpose is to rejuvenate tissues in the body by replacing them with undifferentiated germ cells. Lists news releases relating to the company and contact informa |
| Prionics_AG Focused on developing diagnostic tests for prion diseases, and other neurological disorders. |
| Procorde_GmbH Biotechnology research in heart disease. |
| Prometic_-_Life_Science,_Inc_ Targets bioseparation and medical applications with its platform technologies, exploiting its proprietary synthetic ligands designed to effect very specific interactions with proteins. |
| Protéus Discovers biomolecules for large global markets. |
| PTC_Therapeutics Focused on the discovery and commercialization of orally active small molecule therapeutics for human diseases. |
| Research_Point_Corporation Online resource and information tools for the scientific and pharmaceutical communities. |
| Scigenic Specializes in the incubation of lab-scale technologies with real market potential to deliver true commercial success. |
| SIGNALS_Magazine Online magazine for biotechnology, biomedical, and pharmaceutical industry analysis. |
| Sigris_Research,_Inc_ Utilizes biomagnetic mixing and bioseparation technology to isolate and extract genomic DNA, mRNA, and cell proteins. |
| Synergene_Biotech_GmbH Offers DNA sequencing services for the life science community. Site includes details of services offered, current projects and company news. |
| Topix_net__Biotech News about the biotechnology industry, collected from various sources on the web.. [RSS] |
| ABC_News_Business_Index Business news and commentary articles. |
| Asia_Asset_Management Information about various asset management categories, including an ezine. |
| BBC_Business Information on setting up in business, managing money, personal finances and making the right career move. |
| BizReport_com News from the world of Internet businesses and e-commerce. Free daily email newsletter available. |
| Bloomberg_com Breaking financial, business and economic news worldwide from major provider of information services. |
| Boardroom_Insider The email newsletter for better boards and better directors. |
| Broadcast_Live-Business Business news provided via television and radio webcasts from Europe, Asia, Australia and North America. |
| Business_In_Depth Using links to newspapers, magazines and internet resources you can read business news from around the world. |
| Business_Nation Provides business, finance, technology and industry news categorized in 150+ categories which is extracted and aggregated from over 1000+ news sources from all over the world. |
| Business_News_-_Topix_net News on business continually updated from thousands of sources around the net. |
| Business_Psychology_News Newsletter addressing business psychology issues, including business humor, men and women in business, employee retention, successful management, and worker-friendly policies. |
| Business_To_Business_Travel_Websites_Group A travel resource and news portal focusing on the business traveller. |
| Business_Wire Source of current business and industry news direct from press releases. |
| BusinessToday_org Website of the largest student-run publication in America. |
| CBC_Business_News Business news from the Canadian Broadcasting Corporation, CBC. |
| CEO_Online Total business resource at one location on the web. |
HOME Company Background Leadership Team Board of Directors Advisors Business Strategy Quality Systems ABOUT US Technology Overview MaxCyte Platform System Applications Immunotherapy Regenerative Medicine Viral Vectors Cell-Based Screening[non-clinical] TECHNOLOGY Overview Business Strategy Academic Collaborators Partners Licensing CORPORATE DEVELOPMENT Press Releases Publications/Posters Conferences NEWS & EVENTS Contact Info Employment Opportunities Driving Directions CONTACT US 
Corporate Profile [Click Here] Chinese Translation [Click Here] 
MaxCyte is a clinical-stage cell therapeutics company with a rapidly growing pipeline of product development partnerships in cell-based therapies. The Company's proprietary, non-viral, ex vivo cell loading technology provides safety, scalability and reproducibility capabilities which are fundamental to commercializing successful cell-based therapies. MaxCyte has demonstrated the value of its versatile technology in partnered therapeutic programs in oncology, pulmonary, metabolic and infectious diseases as well as in development collaborations with leading researchers. Current clinical programs with MaxCyte-engineered cells include: a Phase IIa clinical study for treatment of chronic lymphocytic leukemia (CLL) and a Phase IIa study using engineered stem cells for the treatment of primary Pulmonary Arterial Hypertension (PAH). MaxCyte has recently partnered with Medinet (JP) to commercialize a cell based therapy to be launched in 2008. In addition, there are advanced preclinical programs in oncology and regenerative medicine. More than 16 commercial and academic partners are currently using the MaxCyte technology. The MaxCyte system has an FDA Master File in place at the Center for Biologics Evaluation and Research (CBER). news & events 08/20/08 - Medinet Starts Commercialization of Novel Cancer Immunotherapy Technology in Japan read more... 06/16/08 - MaxCyte to Present at 2008 BIO International Convention read more... 04/21/08 - Breakthrough Large Scale Transfection Technology Accelerates Cell-Based Assay Development read more... 04/07/08 - MaxCyte to Present at BIO-Europe Spring 2008 Conference read more... 02/26/08 - MaxCyte to Present at the 3rd Annual Stem Cell Summit read more... 02/06/08 - MaxCyte to Present at the BIO CEO & Investor Conference read more... 01/28/08 - MaxCyte to Present at the Phacilitate Cell and Gene Therapy Forum 2008 read more... 11/28/07 - Binex and MaxCyte Collaborate on Cancer Immunotherapy Research read more... 08/27/07 - Medinet Licenses MaxCyte Cell Loading Technology For Cancer Immunotherapy in Japan read more... 06/22/07 - MaxCyte and Medinet to present at the 13th Annual Meeting of the International Society for Cellular Therapy (ISCT) in Sydney, Australia read more... 06/20/07 - MaxCyte To Present at BIOTECH CHINA 2007 read more... 06/13/07 - MaxCyte to Speak at TERMIS North America 2007 Conference & Exposition read more... 05/29/07 - MaxCyte to Present at American Society for Gene Therapy (ASGT) 10th Annual Meeting read more... conferences Jan 7 - 10, 2008: 26th Annual JP Morgan Healthcare Conference Jan. 28 - 30, 2008: Phacilitate Cell & Gene Therapy Forum 2008 Feb 11 - 13, 2008: BIO CEO & Investor Conference Feb 26, 2008: 3rd Annual Stem Cell Summit April 7 - 9, 2008: BIO-Europe Spring 2008 Apr 21 - 24, 2008: World Vaccine Congress 2008 May 17 - 20, 2008: 14th Annual Meeting of the International Society of Cellular Therapy May 28 - Jun 1, 2008: ASGT 11th Annual Meeting Jun 17 - 20, 2008: 2008 BIO International Convention Oct 1 -5, 2008: 10th International Symposium on Dendritic Cells Oct 8 - 10, 2008: BioKorea 2008 Oct 22 - 24, 2008: Mid-Atlantic Bio Home | About Us | Technology | Corporate Development | News & Events | Contact Us | Sitemap 22 Firstfield Road, Suite 250, Gaithersburg, MD 20878 * 301-944-1700 